journal article·2024-06-19

A New Capillary-Channel Agarose Sponge Assembled with Deep Eutectic Solvent Based Magnetic Fluid for Rapid Hemostasis and Prevention of Bacterial Infection

Yingying Guo, Yueshan Li, Yu Chen, Ahmad Ali, Shun Yao

ACS Applied Materials & Interfaces· Volume 16· Issue 24
Publisher page

Abstract

A new composite sponge assisted by magnetic field-mediated guidance was developed for effective hemostasis. It was based on polydopamine capillary-channel agarose (PDA-CAGA) sponge as matrix; meanwhile, the combination of deep eutectic solvent (DES, choline chloride:glycerol = 1:1, M/M)-dispersed Fe 3 O 4 nanoparticles after fabrication by tannic acid (DES-Fe 3 O 4 @TA) was applied as hemostatic magnetic fluid. This sponge had oriented and aligned capillary channels realized by a 3D printed pattern, which endowed them with obvious shape memory and liquid absorption performance. Computational simulation was performed to describe the fluid status in channels; DES-Fe 3 O 4 @TA exhibited good magnetic properties, fluidity, and stability. In addition, the sponge driven to react rapidly with the bleeding site under the effect of a magnetic field presented a shorter hemostasis time (reduced by 85.02% in the tail and 81.07% in the liver of rats) and less blood loss (reduced by 97.08% in the tail and 91.50% in the liver) than those of medical gelatin sponge (GS). Meanwhile, the multifunctional material also exhibited better biocompatibility, procoagulant performance, and significant inhibition on S. aureus and E. coli than GS. As a whole, this work proposed a new strategy for rapid hemostasis by designing a magnetic field assisted composite bacteriostatic material, which also expanded the applications of green solvents in the clinical management field.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Hemostasis and retained surgical items · Polymer Surface Interaction Studies · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Chemical Engineering, Sichuan University, Chengdu 610065, China

School of Pharmacy, Chengdu Medical College, Chengdu 610500, China

Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China

South Sichuan Institute of Translational Medicine, School of Pharmacy, Southwest Medical University, Luzhou 646000, China

Funding

Natural Science Foundation of Sichuan Province · Chengdu Key Research and Development Supporting Project · Sichuan University-Luzhou Science and Technology Innovation Platform Construction Project · Chengdu Medical College high Level Talent Cultivation Project

References (48)

Show source-provided references
1. 10.1016/j.carbpol.2021.11848210.1016/j.carbpol.2021.118482 ↗
2. 10.1016/j.actbio.2019.08.03910.1016/j.actbio.2019.08.039 ↗
3. 10.1002/adma.20150242210.1002/adma.201502422 ↗
4. 10.1021/nn503719n10.1021/nn503719n ↗
5. 10.1039/C9MH01255A10.1039/C9MH01255A ↗
6. 10.1016/j.cej.2021.12981510.1016/j.cej.2021.129815 ↗
7. 10.1039/C8NR05882B10.1039/C8NR05882B ↗
8. 10.1016/j.jconrel.2022.03.02710.1016/j.jconrel.2022.03.027 ↗
9. 10.1016/j.actbio.2020.07.04310.1016/j.actbio.2020.07.043 ↗
10. 10.1016/j.carbpol.2022.11957410.1016/j.carbpol.2022.119574 ↗
11. 10.1016/j.bioadv.2023.21348110.1016/j.bioadv.2023.213481 ↗
12. 10.1016/j.jconrel.2020.07.02810.1016/j.jconrel.2020.07.028 ↗
13. 10.1021/acs.biomac.7b0176410.1021/acs.biomac.7b01764 ↗
14. 10.1038/s41467-021-24972-210.1038/s41467-021-24972-2 ↗
15. 10.1016/j.smaim.2020.07.00110.1016/j.smaim.2020.07.001 ↗
16. 10.1016/j.bioactmat.2021.05.00610.1016/j.bioactmat.2021.05.006 ↗
17. 10.34133/2022/976274610.34133/2022/9762746 ↗
18. 10.1016/j.cej.2021.13091610.1016/j.cej.2021.130916 ↗
19. Tang Z. F. · Chinese Journal of Experimental Surgery · 2011 · 8 · 1337
20. 10.1021/acsami.0c2091610.1021/acsami.0c20916 ↗
21. 10.3390/app11231130110.3390/app112311301 ↗
22. 10.5935/0103-5053.2015032210.5935/0103-5053.20150322 ↗
23. 10.1186/s12951-023-01922-210.1186/s12951-023-01922-2 ↗
24. 10.1016/j.compositesb.2021.10904710.1016/j.compositesb.2021.109047 ↗
25. 10.1016/j.carbpol.2022.11993910.1016/j.carbpol.2022.119939 ↗
26. 10.1016/j.cej.2023.14185910.1016/j.cej.2023.141859 ↗
27. 10.1002/jssc.20190023410.1002/jssc.201900234 ↗
28. 10.1016/j.molliq.2018.07.06310.1016/j.molliq.2018.07.063 ↗
29. 10.1021/am501391z10.1021/am501391z ↗
30. 10.1021/acsami.1c0242110.1021/acsami.1c02421 ↗
31. 10.1016/j.bioactmat.2021.04.04010.1016/j.bioactmat.2021.04.040 ↗
32. 10.1016/j.cej.2019.04.10710.1016/j.cej.2019.04.107 ↗
33. 10.1016/j.jaad.2022.06.55710.1016/j.jaad.2022.06.557 ↗
34. 10.1021/acsaelm.3c0007510.1021/acsaelm.3c00075 ↗
35. 10.1002/jssc.20170010310.1002/jssc.201700103 ↗
36. 10.1016/j.foodchem.2018.12.12510.1016/j.foodchem.2018.12.125 ↗
37. 10.1016/j.talanta.2019.05.02710.1016/j.talanta.2019.05.027 ↗
38. 10.1038/s41467-018-04998-910.1038/s41467-018-04998-9 ↗
39. 10.1023/A:100896173092910.1023/A:1008961730929 ↗
40. 10.1021/acsami.9b0461510.1021/acsami.9b04615 ↗
41. 10.1017/jfm.2020.8010.1017/jfm.2020.80 ↗
42. 10.1039/C8NR08987F10.1039/C8NR08987F ↗
43. 10.1021/acs.chemmater.0c0203010.1021/acs.chemmater.0c02030 ↗
44. 10.1021/acsami.9b1754310.1021/acsami.9b17543 ↗
45. 10.1016/j.nantod.2022.10172010.1016/j.nantod.2022.101720 ↗
46. 10.3389/fphar.2021.80689110.3389/fphar.2021.806891 ↗
47. Gu P. F. · Polym. Bull. · 2018 · 12 · 17
48. 10.1016/j.msec.2021.11222710.1016/j.msec.2021.112227 ↗